rss
Br J Ophthalmol 2009;93:688-691 doi:10.1136/bjo.2008.151233
  • Clinical science
    • Original Article

Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)

  1. D da R Lucena1,
  2. J A S Ribeiro1,
  3. R A Costa1,2,
  4. J C Barbosa3,
  5. I U Scott4,
  6. L L de Figueiredo-Pontes5,
  7. R Jorge1
  1. 1
    Department of Ophthalmology, School of Medicine of Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil
  2. 2
    MacIma—Macular Imaging & Treatment Division, Hospital de Olhos de Araraquara, Araraquara, São Paulo, Brazil
  3. 3
    Department of Exact Sciences, São Paulo State University, Jaboticabal, São Paulo, Brazil
  4. 4
    Departments of Ophthalmology and Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA
  5. 5
    Laboratory of Hematology, School of Medicine of Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil
  1. Professor R Jorge, Setor de Retina e Vítreo, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Avenida Bandeirantes 3900, Ribeirão Preto-SP, CEP 14049-900, Brasil; rjorge{at}fmrp.usp.br
  • Accepted 20 December 2008
  • Published Online First 10 February 2009

Abstract

Aims: To compare the amount of intraoperative intraocular bleeding in patients with diabetes with macula-involving tractional retinal detachment (TRD) undergoing pars plana vitrectomy (PPV) with and without preoperative intravitreal bevacizumab (IVB) injection.

Methods: An institutional study was carried out with consecutive patients with diabetic retinopathy and macula-involving TRD of recent (3 months) onset who were randomly assigned to PPV only (PPV group) or PPV combined with one IVB (1.5 mg/0.06 ml) injection 2 weeks prior to surgery (bevacizumab (BEV)/PPV group). All patients underwent 23-gauge PPV 3 weeks after baseline. The main outcome measure was erythrocyte count in the fluid retrieved from the vitrectomy cassette using a Neubauer counting chamber.

Results: The study included 20 patients. The mean erythrocyte count was 14 865×103 (SD 19 332×103; median 4500×103) cells in the BEV/PPV group, and 176 240×103 (SD 108 375×103; median 166 600×103) cells in the PPV group. The mean erythrocyte count was significantly lower in the BEV/PPV group than in the PPV group (p<0.0001). No major adverse events were identified.

Conclusion: Preoperative IVB injection was associated with reduced intraocular bleeding during 23-gauge PPV for diabetic macula-involving TRD. Further studies are needed to confirm our preliminary findings.

Trial registration number: NCT00690768.

Footnotes

  • Competing interests: None.

  • Funding: Partially supported by CNPq (Brazilian National Council for Scientific and Technological Development), grant no 302940/2005-7.

  • Ethics approval: Ethics approval was provided by the local institutional review board (Comitê de Ética em Pesquisa HCRP e FMRP-USP).

  • Patient consent: Obtained.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. bjo.2008.151233v1
    2. 93/5/688 most recent

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.